SARS Situation in Guangdong and Hospital Infection Control Xiaoping Tang, M.D, Ph.D Guangzhou No. 8 People’s Hospital.

Slides:



Advertisements
Similar presentations
© Gavin Joynt & Florence Yap April 2003 SARS - ICU presentation and management Dr Gavin Joynt and Dr Florence Yap.
Advertisements

Outbreak Investigation Severe Acute Respiratory Syndrome SARS April 2003.
The 1 st New Disease of the 21 st Century by Otto Sanchez MD MSc PhD Faculty of Health Sciences University of Ontario Institute of Technology June 2004.
PATHOPHYSIOLOGY OF INFLUENZA
SARS. Introduction SARS, a highly contagious disease that originated in China, has killed more than 200 people and infected nearly 3,900 others in 25.
What is Pneumonia and How Do I Prevent it?
MERS-CoV: Reporting and Laboratory Testing Republic of Lebanon Ministry of Public Health Epidemiological Surveillance Program May 2014.
H1N1.
COPD Research at the University of Maryland School of Maryland COPD Clinical Research Center A member of the National Heart Lung & Blood Institute National.
Gilead -Topics in Human Pathophysiology Fall 2009 Drug Safety and Public Health.
Outbreak of Severe Acute Respiratory Syndrome (SARS) in Hong Kong The Hong Kong Medical Association.
My Life Monday What do you know about SARS? Before moving on to the explanation of the illness, the abbreviation stands for Severe Acute Respiratory Syndrome.
SARS The Toronto Outbreak April 20, SARS in Toronto I: Index Case February 23 – A 78 year old woman arrives back in Toronto from trip to Hong Kong.
Managing acute exacerbations of COPD in primary care.
SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 March 11 March 12 March 19 March 27 April 5 April 9 April 14 April 17 April 28 First cases Hong Kong WHO Sequence.
SARS outbreak. SARS Outbreak March 107 MDs and 4 nurses reported sick March 1150 staff screened, 23 admitted, ward closed March 12Clinical teaching suspended.
SARS outbreak. SARS Outbreak March 107 MDs and 4 nurses reported sick March 1150 staff screened, 23 admitted, ward closed March 12Clinical teaching suspended.
A case of haemoptysis ERWEB Case.
Department of the Navy The different age-distribution of the mortality of the 1918 influenza from normal epidemics. Deaths by age at death,
INTERSTITIAL LUNG DISEASE
Welcome Submitted by:- Joshi Aditi Reg.No: Submitted to:- Dr. Anurag yadav.
Public Health Update David Kirschke, MD Medical Director / Health Officer Northeast Tennessee Regional Health Office.
BRONCHITIS By: Justyna, Joanna, and Andriy. WHAT IS BRONCHITIS? Bronchitis is a respiratory disease that causes the mucous membrane lining the bronchial.
Clinical Pathological Conference Kartikya Ahuja, M.D. Resident Physician Department of Medicine NYU School of Medicine July 20 th, 2007.
H1N1 General Information Update Karen Dahl, MD Pediatric Infectious Diseases.
An International Case Study of Lung Transplantation
Enzyme Case Studies: 1 A 67 year old male two days after sustaining multiple injuries in a motor vehicle accident complains of chest pain. There is no.
Severe Acute Respiratory Syndrome (SARS) Michael Leonard.
Case Management of Suspect Human Avian Influenza Infection
Pandemic Influenza. Guidance for Pandemic Influenza: Infection Control in Hospitals and Primary Care Settings UK Pandemic Influenza Contingency Plan Operational.
TANEY COUNTY HEALTH DEPARTMENT AUGUST 2009 Situation Update: H1N1 Influenza A.
H1N1 VIRUS SWINE FLU. What is the H1N1 Virus? It is a new virus that is spread from person to person first detected in people in the United States in.
Bashaer Mohammedsaleh.  Middle East Respiratory Syndrome Coronavirus.  Causes Respiratory failure  With small number of reported cases, info about.
Severe Acute Respiratory Syndrome (SARS) –Caused by previously unknown virus, coronavirus (SARS-CoV). –No direct cure, no vaccination. –First appeared.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
H1N1 Update Marty White October 12, H1N1 Information  Pandemic declared by World Health Organization in June 2009  The symptoms include fever,
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
SARS. What is it? SARS stands for severe acute respiratory syndrome. It is a respiratory disease caused by the SARS coronavirus.
Clinical Aspects of Severe Acute Respiratory Syndrome (SARS), 2003 John A. Jernigan, MD, MS For the SARS Clinical/Infection Control Investigative Team.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Esam H. Alhamad, M.D Assistant Professor of Medicine Consultant Pulmonary & Critical Care Medicine.
Country update on AI situation Ly Sovann, MD, DTMH, MCTM Deputy of CDC Department, MoH, Cambodia.
Lung cancer By Hanchu Zhang, Billy Shi and Hongyu Mao.
BIOS 162 Graduate Review: Final! December 11, 2011.
SARS. What is SARS? Severe Acute Respiratory Syndrome Respiratory illness Asia, North America, and Europe Previously unrecognized coronavirus.
Jeremy Buige 2B.
How SARS Works. Originally, the World Health Organization (WHO) defined severe acute respiratory syndrome (SARS) as an "atypical pneumonia of unknown.
VILNIUS UNIVERSITY HOSPITAL SANTARISKIU KLINIKOS.
SEVERE ACUTE RESPIRATORY SYNDROME – UPDATE Anne-Claire de Benoist and Delia Boccia, European Programme for Intervention.
Severe Acute Respiratory Syndrome (SARS) Introduction.
 What are the signs to diagnose severe pneumonia?  Enumerate 4 organisms for community acquired pneumonia.
Severe acute respiratory syndrome. SARS. SARS is a communicable viral disease caused by a new strain of coronavirus. The most common symptoms in patient.
Lung disorders Advanced Biology Stem Cells Forming An Artificial lung.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
Communicability Patient factors Not infectious prior to symptoms Increases with increased severity of disease Increases post-onset symptoms (peak at day.
Outbreak of Severe Acute Respiratory Syndrome (SARS) in Hong Kong
SARS Severe acute respiratory syndrome. History Outbreak in south China. Spread to other countries and regions. Identification of virus. Containment.
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Agilent Restricted Influenza H1N1 A (Swine Influenza) Information for Agilent’s Employees.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Simon Barry Cardiff November 2015
The Origin and Evolution of SARS Dept. of Microbiology, Faculty of Medicine, The University of Hong Kong The First Affiliated Hospital, Guangzhou Med.
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Qun Li, M.D., Lei Zhou, M.D., Minghao Zhou, Ph.D., Zhiping Chen, M.D., Furong.
Louise Gribben Haematology CNS HAI 2016
H1N1 Swine Flu Overview by ziffi.com Symptoms, Causes, Prevention, Tests, Test & Vaccination Centers.
Severe Acute Respiratory Syndrome (SARS)
DEPARTMENT OF MEDICINE, UOM
Philip Huang, MD, MPH Director/ Health Authority
Presentation transcript:

SARS Situation in Guangdong and Hospital Infection Control Xiaoping Tang, M.D, Ph.D Guangzhou No. 8 People’s Hospital

Number Of SARS Patients and HCW Infection (AS of 8/7/2003) Cases Death (%) HCW(%) Last Report Global (20) 7.13 China (Main) (19) 6.25 Guangdong (23) 6.25 Hongkong (22) 5.31 Taiwan (13) 6.15 Canada (43) 6.12 Singapore (41) 5.05

Foshan Cases  In November, 2002 A cluster of 5 cases of Pneumonia from one family were hospitalized, 2 developed to RF ( First case : onset time Nov 16 )  Large shadows in Lungs  No Response to Antibiotics X-Ray

Heyuan Cases Mr. Huang, a restaurant cook, got sick on Dec.10 in Shenzhen admitted to Heyuan 1 st Hospital on Dec.15 , 2002 A cluster of cases including 8 HCW happened First case in Heyuan

Zhongshan Cases January 20, 20 cases were reported to Guangdong Health Bureau. Jan. 21, experts from Guangzhou, Foshan, Heyuan and China CDC had consultation together.

Guangzhou Super-spreader

90

Total Patients Received 1 st patients: Feb 2, 2003 Total : 413 probable & suspect cases (262 confirmed )

Male 124 Female 138 Age 2-89 years old average 41±18 SARS contacting history 175 (67.3%) Incubation period 1-14 d average 4.5 d General Information

Clinical features (%)Hong Kong Lee et al (n=138) Toronto Booth et al (n=144) Hong Kong Peiris et al (n=50) Guangzhou Zhang et al (n=260) Singapore Hsu et al (n=20) Fever Chills/rigor Myalgia Cough Dyspnoea Headache Dizziness Sputum Diarrhoea Nausea & vomiting Sore throat Malaise Presenting Symptoms

Laboratory Findings (1) Leucocyte >10 ×10 9 /L 38 (14.6%) 4.0~10 ×10 9 /L 146 (56.2%) < 4.0 ×10 9 /L 76 (29.2%) < 2.0 ×10 9 /L 35 (13.5%) Lymphocyte < 1.5 ×10 9 /L 226 (86.9%) Platelet < 10 × 10 9 /L 25 (9%) the lowest 2.5 × 10 9 /L

Laboratory Findings (2) LDH increase 121 (46.5%) CK increase 106 (40.8%) ALT increase 174 (66.9%) AST increase 136 (52.3%) BUN 28 (10.8%)

CD4 + lymphocyte ± 405.2/ul < 400/ul 56/93 (60.2%) < 200/ul 30/93 (32.3%) the lowest 23/ul SO2 < 95% 101 (38.8%) Laboratory Findings (3)

T Lymphocyte Subtypes (1)

T Lymphocyte Subtypes (2)

Chest X-ray Interstitial damage 184 (70.7%) Small patch-like or spotty shadow 195 (75%) Large patch-like shadow 161 (61.9%) Reticular opacities 93 (35.8%) Both lung involvement 192 (73.8%)

Management Oxygen taking Antibiotics: empirically Anti-viral reagents : Ribavirin Glucocorticoid (Methyprednisolone) Artificial Ventilator support

Corticosteroid Management Early systemic corticosteroid administration Autopsy showed: hyalinization of airway basal membrane, alveolar fibrosis (similar to ARDS) Indication: High fever>3 days Chest X ray deteriorates progressively

Dose of methylprednisolone in Guangzhou No.8 Hosp Dose of MP 140±123mg/d (40~500mg/d) Duration 14±12 days N=54

No-invasive Positive Pressure Ventilation (CPAP/BiPAP) Indications: 1. RR>30times/min ; 2.SaO 2 < 93% when taking oxygen 3-5L/min 3 、 Difficulty in breathing No.8 Hosp. N=54/262

Average time of hospitalization Common type 13.8 ± 3.5 d Severe type 28.4 ± 10.3 d Fatality rate 4.2% (12/260) Prognosis

Mortality in Guangzhou Total cases 1274 Dead % 70% (892 cases) with IgG titer 4 times higher than normal 5.16% Mortality 46/892 = 5.16%

Low mortality in Guangdong (why?) (1) Misdiagnosis Less worse epidemics – Peak < 60 newly diagnosed pts/day Age distribution ? Fewer patients with underlying diseases?

Low mortality in Guangdong (why?) (2) Critical Cases Medical staff Guideline - better efficacy with combined management (lower dose corticosteroid +CPAP/BiPAP) referred to well-equipped and well-trained hospitals

Distribution of death relating to age (n=931) Age (yrs) < >70Total Case Death %

Underlying Disease relating to death (n=931) TotalWith underlying disease No underlying disease Case (20.4%) 741 (79.6%) Death % Underlying diseases—Diabetes, COPD, chronic asthma, cancer, chronic renal disease, hypertension, pulmonary TB, chronic hepatitis, chronic heart failure, etc

A comparison of Intubation Rate and Crude Fatality Rate in SARS patients NCPAP(BiPAP)IntubationFatality Hong Kong (2.0%) 246 (14.0%) 300 (17.1%) Guangzhou (23.1%) 39 (7.4%) 29 (5.5%) P (X 2 test) <0.001 (228.3) <0.001 (16.3) <0.001 (43.6)

Hospital Infection Control

Number Of SARS Patients and HCW Infection (AS of 8/7/2003) Cases Death (%) HCW(%) Last Report Global (20) 7.13 China( Main ) (19) 6.25 Guangdong (23) 6.25 Hongkong (22) 5.31 Taiwan (13) 6.15 Canada (43) 6.12 Singapore (41) 5.05

Medical Staff Infection in Our Hospital Total 20 (8 doctors, 12 nurses) Happened during the time when there were most patients ( from Feb. 12 to Feb.19 ) All recovered

After Bitter Experiences More Strict Hospital Preventive Measures were Taken by Medical Staff

Separated Fever Clinic

Thank You !